Pharmafile Logo
Pharmafocus logo
Advanced Search

Iressa successor enters phase III

July 19, 2005
Research and Development, Sales and Marketing

AstraZeneca's oncology compound ZD6474 has entered phase III trials after positive results in trials in non-small cell lung cancer.The drug, …

News

AstraZeneca invests in novel cholesterol drugs

July 15, 2005
Research and Development

AstraZeneca is investing in a range of next generation cholesterol drugs which could reverse existing vascular disease in patients.The Anglo-Swedish …

News

Arimidex approved for post-surgery cancer prevention

July 13, 2005
Sales and Marketing

News

Getting inside the customer’s head

July 11, 2005
Sales and Marketing

Doctors are a diverse group of people. From GPs to specialists, with the more than 60 areas of medicine that …

Feature

Because they’re worth it?

July 11, 2005
Sales and Marketing

Feature

NHS tsar calls on clinicians to reassess clinical practice

July 11, 2005

The NHS tsar for primary care has called on clinicians to challenge the way they undertake clinical practice in order …

News

‘Virtual super surgeries’ the future for primary care

July 8, 2005

Plans to redesign the primary care landscape with the creation of purpose-built super surgeries are in many cases unfeasible, according …

News

GSK win for Euro RSCG Life MSC

July 7, 2005
Medical Communications

GlaxoSmithKline has awarded the pan-European launch of a major new neurological product to Euro RSCG Life MSC, following a three-way …

News

ABPI sets up links to clinical trials databases

July 7, 2005
Sales and Marketing

Website links to details of more than 4,000 clinical trials have been published by the ABPI, as the global agreement …

News

Pfizer pulls out of Daxas collaboration

July 7, 2005
Sales and Marketing Daxas, Nycomed, Pfizer

Pfizer has pulled out of an agreement with Altana Pharma to develop and market a new treatment for asthma and …

News

One Europe for pharma marketers?

July 6, 2005
Sales and Marketing

Pharma economists will tell you that the world has a market 'top three'. The US is way ahead in the …

Feature

No more Alton Towers? UK pharma downsizes its hospitality

July 6, 2005
Sales and Marketing

UK-based pharmaceutical companies have pre-empted strict new European rules on entertaining healthcare professionals by imposing their own restrictions.The companies are …

News

‘Ticking time bomb’ will go off as NHS investment slows

July 6, 2005

News

Lilly buys rights to novel diabetes drug

July 6, 2005
Research and Development, Sales and Marketing

Eli Lilly has signed a licensing agreement with Japanese pharmaceutical company Taisho for TS-021, a novel treatment for type II …

News

Orphans join European pharma family

July 5, 2005
Sales and Marketing

Feature

Antidepressants come under FDA review again

July 4, 2005
Sales and Marketing

The FDA is conducting another review of antidepressants to determine whether the drugs increase the risk of suicidal behaviour in …

News

GSK excited about new vaccines

July 4, 2005
Sales and Marketing

GlaxoSmithKline has updated investors on its vaccine pipeline, with the company expecting to launch five major vaccines within as many …

News

Doctors have no time to mentor nurse prescribers

June 30, 2005

Doctors have expressed concern that they do not have time to act as mentors to independent nurse prescribers, according to …

News

NHS to save

June 30, 2005

News

Bright future for new antidepressants

June 30, 2005
Research and Development, Sales and Marketing

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026